WILLS STEPHEN T

SEC source: 0001654954-23-010938 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,289

F5 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 22, 2023, the date of vesting. The grant and vesting of the underlying 3,196 restricted share units was reported on Form 4 filed on June 22, 2023, with a transaction date of June 20, 2023.

F5 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 22, 2023, the date of vesting. The grant and vesting of the underlying 3,196 restricted share units was reported on Form 4 filed on June 22, 2023, with a transaction date of June 20, 2023.

SEC source: 0001654954-23-010938 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,165

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F4 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 22, 2023, the date of vesting. The grant of the underlying 6,090 time-based restricted share units, which vested on June 22, 2023, was reported on Form 4 filed on June 24, 2021.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F4 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 22, 2023, the date of vesting. The grant of the underlying 6,090 time-based restricted share units, which vested on June 22, 2023, was reported on Form 4 filed on June 24, 2021.

SEC source: 0001654954-23-010938 · section16.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,835

F3 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 16, 2023, the date of vesting. The grant and vesting of the underlying 4,543 restricted share units was reported on Form 4 filed on June 22, 2023, with a transaction date of June 20, 2023.

F3 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 16, 2023, the date of vesting. The grant and vesting of the underlying 4,543 restricted share units was reported on Form 4 filed on June 22, 2023, with a transaction date of June 20, 2023.

SEC source: 0001654954-23-010938 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,081

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F2 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 16, 2023, the date of vesting. The grant of the underlying 5,570 time-based restricted share units, which vested on June 16, 2023, was reported on Form 4 filed on June 18, 2020 as to one half of the total grant, and on Form 4 filed on June 26, 2020 as to the remaining one half, which had been granted contingent on increasing the shares reserved for grant under the 2011 Stock Incentive Plan, which was approved the stockholders at a meeting on June 25, 2020.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F2 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended August 15, 2023, with the per share value determined as of June 16, 2023, the date of vesting. The grant of the underlying 5,570 time-based restricted share units, which vested on June 16, 2023, was reported on Form 4 filed on June 18, 2020 as to one half of the total grant, and on Form 4 filed on June 26, 2020 as to the remaining one half, which had been granted contingent on increasing the shares reserved for grant under the 2011 Stock Incentive Plan, which was approved the stockholders at a meeting on June 25, 2020.

SEC source: 0001654954-23-008306 · section16.xml · derivative · entry 9

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,672 shares

Expires 2032-06-22

F9 · derivative.exercise_date: Stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 22, 2022, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of stock option shares for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · derivative · entry 8

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,766 shares

Expires 2031-06-22

F8 · derivative.exercise_date: Stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 22, 2021, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of stock option shares for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · derivative · entry 7

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,528 shares

Expires 2030-06-16

F7 · derivative.exercise_date: Stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 16, 2020, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of stock option shares for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · derivative · entry 6

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 90,000 shares

Expires 2033-06-22

F6 · derivative.exercise_date: The options vest at the rate of 25% per year, with the initial vesting on June 20, 2024.

SEC source: 0001654954-23-008306 · section16.xml · nonDerivative · entry 5

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 340,608

F5 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2022, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

F5 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2022, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,139

F4 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2021, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

F4 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2021, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,943

F3 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 16, 2020, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2020 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

F3 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 16, 2020, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2020 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,400

F2 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 24, 2019, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

F2 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 24, 2019, vested in part on June 20, 2023, upon certification by the Compensation Committee that a defined performance objective as to 63% of the target number of share units for the fiscal year ending June 30, 2023 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi. All share numbers in this Form 4 give effect to a 1-for-25 reverse split of issued and outstanding common stock effective on August 30, 2022.

SEC source: 0001654954-23-008306 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,742

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, with the initial vesting on June 20, 2024.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of 25% per year, with the initial vesting on June 20, 2024.

SEC source: 0001209191-23-008533 · doc4.xml · derivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,300

Underlying: Ordinary Shares · 28,300 shares

Expires 2033-02-07

F2 · derivative.exercise_date: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.

SEC source: 0001209191-23-008533 · doc4.xml · derivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,600

Underlying: Ordinary Shares · 56,600 shares

Expires 2033-02-07

F2 · derivative.exercise_date: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.

SEC source: 0001209191-23-008533 · doc4.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,177

F1 · shares: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001209191-23-008533 · doc4.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,977

F1 · shares: Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001654954-22-016963 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,101

SEC source: 0001654954-22-016963 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,841

SEC source: 0001654954-22-016963 · section16.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,741

SEC source: 0001654954-22-016963 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,741

SEC source: 0001654954-22-016987 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,101

F1 · kind: Form 4 is amended to correct that the acquisition of stock was an open market purchase of common stock on an exchange.

SEC source: 0001654954-22-016987 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,841

F1 · kind: Form 4 is amended to correct that the acquisition of stock was an open market purchase of common stock on an exchange.

SEC source: 0001654954-22-016987 · section16.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,741

F1 · kind: Form 4 is amended to correct that the acquisition of stock was an open market purchase of common stock on an exchange.

SEC source: 0001654954-22-016987 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,741

F1 · kind: Form 4 is amended to correct that the acquisition of stock was an open market purchase of common stock on an exchange.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 8

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257,101

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 7

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 282,621

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 6

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,781

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 5

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,681

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,681

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,521

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,321

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001654954-22-016646 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 371,321

F1 · security: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

F1 · kind: The holder of stock options knowingly and voluntarily contributed such options to the 2011 Stock Incentive Plan (the "Plan"), effective as of the Transaction Date, such that the options were terminated and cancelled without payment of any consideration by Issuer, and the holder has no further rights with respect to the options.

SEC source: 0001209191-22-058397 · doc4.xml · derivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,500

Underlying: Ordinary Shares · 9,500 shares

Expires 2032-11-17

F2 · derivative.exercise_date: This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on February 1, 2023, subject to the Reporting Person's continuous service through each such vesting date.

SEC source: 0001209191-22-058397 · doc4.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,677

F1 · shares: Represents a restricted share unit award, which shall vest on November 1, 2023, subject to the Reporting Person's continuous service through such vesting date.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 7

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,941

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F8 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2028 payroll), with the per share value determined as of June 24, 2022, the date of vesting. The grant and vesting of the underlying 1,898 restricted share units was reported on Form 4 filed on June 24, 2022, with a transaction date of June 22, 2022.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F8 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2028 payroll), with the per share value determined as of June 24, 2022, the date of vesting. The grant and vesting of the underlying 1,898 restricted share units was reported on Form 4 filed on June 24, 2022, with a transaction date of June 22, 2022.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 6

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,461

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F7 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 24, 2022, the date of vesting. The grant of the underlying 2,020 time-based restricted share units which vested on June 24, 2022 was reported on Form 4 filed on June 26, 2019.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F7 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 24, 2022, the date of vesting. The grant of the underlying 2,020 time-based restricted share units which vested on June 24, 2022 was reported on Form 4 filed on June 26, 2019.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 5

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,015

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F6 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 22, 2022, the date of vesting. The grant and vesting of the underlying 1,626 restricted share units was reported on Form 4 filed on June 28, 2022, with a transaction date of June 22, 2022.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F6 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 22, 2022, the date of vesting. The grant and vesting of the underlying 1,626 restricted share units was reported on Form 4 filed on June 28, 2022, with a transaction date of June 22, 2022.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,461

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F5 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 22, 2022, the date of vesting. The grant and vesting of the underlying 1,441 restricted share units was reported on Form 4 filed on June 24, 2022, with a transaction date of June 22, 2022.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F5 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 22, 2022, the date of vesting. The grant and vesting of the underlying 1,441 restricted share units was reported on Form 4 filed on June 24, 2022, with a transaction date of June 22, 2022.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,856

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F4 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 22, 2022, the date of vesting. The grant of the underlying 6,090 time-based restricted share units, which vested on June 22, 2022, was reported on Form 4 filed on June 24, 2021.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F4 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 22, 2022, the date of vesting. The grant of the underlying 6,090 time-based restricted share units, which vested on June 22, 2022, was reported on Form 4 filed on June 24, 2021.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 378,526

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F3 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 16, 2022, the date of vesting. The grant and vesting of the underlying 5,097 restricted share units was reported on Form 4 filed on June 24, 2022, with a transaction date of June 22, 2022.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F3 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 16, 2022, the date of vesting. The grant and vesting of the underlying 5,097 restricted share units was reported on Form 4 filed on June 24, 2022, with a transaction date of June 22, 2022.

SEC source: 0001654954-22-014133 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379,924

F1 · shares: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F2 · shares: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 16, 2022, the date of vesting. The grant of the underlying 5,570 time-based restricted share units, which vested on June 16, 2022, was reported on Form 4 filed on June 18, 2020 as to one half of the total grant, and on Form 4 filed on June 26, 2020 as to the remaining one half, which had been granted contingent on increasing the shares reserved for grant under the 2011 Stock Incentive Plan, which was approved the stockholders at a meeting on June 25, 2020.

F1 · price: A certificate of amendment of the articles of incorporation of Palatin Technologies for a 1-for-25 reverse stock split of issued and outstanding common stock (the "Reverse Stock Split") was effective as of 5:00 p.m. Eastern Time on August 30, 2022 (the "Effective Date"). All share and per share numbers herein, including common stock and awards made or vested prior to the Effective Date, have been adjusted to give effect to the Reverse Stock Split.

F2 · price: Shares withheld by the issuer, on election of the Reporting Person with the consent of the issuer, to pay employee withholding taxes. Such taxes were withheld and reported for the payroll in the period ended October 25, 2022 (for the October 28, 2022 payroll), with the per share value determined as of June 16, 2022, the date of vesting. The grant of the underlying 5,570 time-based restricted share units, which vested on June 16, 2022, was reported on Form 4 filed on June 18, 2020 as to one half of the total grant, and on Form 4 filed on June 26, 2020 as to the remaining one half, which had been granted contingent on increasing the shares reserved for grant under the 2011 Stock Incentive Plan, which was approved the stockholders at a meeting on June 25, 2020.

SEC source: 0001209191-22-052305 · doc4.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,677

F1 · price: The reporting person purchased ordinary shares of the Issuer at a price of $1.55 per share in an underwritten public offering by the Issuer, which closed on September 30, 2022.

SEC source: 0001654954-22-008910 · section16.xml · derivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,375

Underlying: Common Stock · 186,375 shares

Expires 2031-06-22

F3 · derivative.exercise_date: Stock options granted under the Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. On June 22, 2021, the Company granted performance-based options to its executive officers which were contingent upon an increase in common stock available for issuance under the Plan, which increase was approved by our stockholders on June 24, 2022. The Compensation Committee certified on June 22, 2022, contingent upon approval of an increase in common stock available under the Plan, that a defined performance objective as to 75% of the target number of stock option shares for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

SEC source: 0001654954-22-008910 · section16.xml · derivative · entry 2

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497,000

Underlying: Common Stock · 497,000 shares

Expires 2031-06-22

F2 · derivative.exercise_date: Stock options granted under the Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. On June 22, 2021, the Company granted time-based options to its executive officers which vest at the rate of 25% per year, starting in June 2022, contingent upon an increase in common stock available for issuance under the Plan, which increase was approved by our stockholders on June 24, 2022

SEC source: 0001654954-22-008910 · section16.xml · nonDerivative · entry 1

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,360,658

F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan (the "Plan"), each of which represents the right to receive, without further payment, one share of common stock. On June 22, 2021, the Company granted performance-based restricted stock units to its executive officers which were contingent upon an increase in common stock available for issuance under the Plan, which increase was approved by our stockholders on June 24, 2022. The Compensation Committee certified on June 22, 2022, contingent upon approval of an increase in common stock available under the Plan, that a defined performance objective as to 75% of the target number of share units for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan (the "Plan"), each of which represents the right to receive, without further payment, one share of common stock. On June 22, 2021, the Company granted performance-based restricted stock units to its executive officers which were contingent upon an increase in common stock available for issuance under the Plan, which increase was approved by our stockholders on June 24, 2022. The Compensation Committee certified on June 22, 2022, contingent upon approval of an increase in common stock available under the Plan, that a defined performance objective as to 75% of the target number of share units for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

SEC source: 0001654954-22-008784 · section16.xml · derivative · entry 6

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,136

Underlying: Common Stock · 211,136 shares

Expires 2030-06-22

F6 · derivative.exercise_date: Stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 16, 2020, vested in part on June 22, 2022, upon certification by the Compensation Committee that a defined performance objective as to 75% of the target number of stock option shares for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

SEC source: 0001654954-22-008784 · section16.xml · derivative · entry 5

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 587,500

Underlying: Common Stock · 587,500 shares

Expires 2032-06-22

F5 · derivative.exercise_date: The options vest at the rate of 25% per year, starting on June 22, 2023.

SEC source: 0001654954-22-008784 · section16.xml · nonDerivative · entry 4

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,319,999

F4 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2021, vested in part on June 22, 2022, upon certification by the Compensation Committee that a defined performance objective as to 75% of the target number of share units for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

F4 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2021, vested in part on June 22, 2022, upon certification by the Compensation Committee that a defined performance objective as to 75% of the target number of share units for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

SEC source: 0001654954-22-008784 · section16.xml · nonDerivative · entry 3

WILLS STEPHEN T · CIK 0001103883 · Executive VP and CFO/COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,283,971

F3 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 16, 2020, vested in part on June 22, 2022, upon certification by the Compensation Committee that a defined performance objective as to 75% of the target number of share units for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.

F3 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 16, 2020, vested in part on June 22, 2022, upon certification by the Compensation Committee that a defined performance objective as to 75% of the target number of share units for the fiscal year ending June 30, 2022 had been achieved, based on performance criteria relating to advancement of melanocortin receptor-1 programs, including initiation of clinical trials, and progress in commercialization of Vyleesi.